Evening primrose oil and borage oil in rheumatologic conditions
Open Access
- 1 January 2000
- journal article
- review article
- Published by Elsevier BV in The American Journal of Clinical Nutrition
- Vol. 71 (1), 352S-356S
- https://doi.org/10.1093/ajcn/71.1.352s
Abstract
Diets rich in arachidonic acid (20:4n−6) lead to the formation of 2-series prostaglandins (PGs) and 4-series leukotrienes (LTs), with proinflammatory effects. Nonsteroidal antiinflammatory drugs are used in rheumatoid arthritis to inhibit cyclooxygenase (prostaglandin-endoperoxide synthase), thereby decreasing production of 2-series PGs. Lipoxygenase activity remains intact, however, allowing LT production (eg, synthesis of LTB4, a potent inflammatory mediator) to continue. Altering the essential fatty acid (EFA) content of the diet can modify some of these effects. Ingestion of a diet rich in evening primrose oil elevates concentrations of dihomo-γ-linolenic acid (DGLA; 20:3n−6), which results in the production of 1-series PGs, eg, PGE1. DGLA itself cannot be converted to LTs but can form a 15-hydroxyl derivative that blocks the transformation of arachidonic acid to LTs. Increasing DGLA intake may allow DGLA to act as a competitive inhibitor of 2-series PGs and 4-series LTs and thus suppress inflammation. The results of in vitro and animal work evaluating EFAs in inflammatory situations are encouraging, which has stimulated clinical workers to evaluate these compounds in rheumatoid arthritis. Several well-controlled, randomized clinical studies have now been completed in which various EFAs were evaluated as treatments. The results of most of these studies suggest some clinical benefit to these treatments; these data are reviewed here.This publication has 26 references indexed in Scilit:
- n‐3 Polyunsaturated fatty acids: update 1995European Journal of Clinical Investigation, 1995
- A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF EFAMOL MARINE ON SKIN AND JOINT SYMPTOMS OF PSORIATIC ARTHRITISRheumatology, 1994
- EFFECTS OF FISH OIL SUPPLEMENTATION ON NON-STEROIDAL ANTI—INFLAMMATORY DRUG REQUIREMENT IN PATIENTS WITH MILD RHEUMATOID ARTHRITIS—A DOUBLE-BLIND PLACEBO CONTROLLED STUDYRheumatology, 1993
- Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.Annals Of The Rheumatic Diseases, 1993
- Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective studyAmerican Journal Of Medicine, 1989
- Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids.Annals Of The Rheumatic Diseases, 1989
- Evening primrose oil (efamol) as a treatment for cold-induced vasospasm (Raynauds Phenomenon)Progress in Lipid Research, 1986
- Patients with Primary Sjögren's Syndrome Treated for Two Months with Evening Primrose OilScandinavian Journal of Rheumatology, 1986
- Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndromeMedical Hypotheses, 1984
- Treatment of Rheumatoid Arthritis with Prostaglandin E1, Precursors CIS-Linoleic Acid and γ-Linolenic AcidScandinavian Journal of Rheumatology, 1983